6-Nitrobenzimidazole derivatives: Potential phosphodiesterase inhibitors: Synthesis and structure-activity relationship

30Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

6-Nitrobenzimidazole derivatives (1-30) synthesized and their phosphodiesterase inhibitory activities determined. Out of thirty tested compounds, ten showed a varying degrees of phosphodiesterase inhibition with IC 50 values between 1.5 ± 0.043 and 294.0 ± 16.7 μM. Compounds 30 (IC 50 = 1.5 ± 0.043 μM), 1 (IC 50 = 2.4 ± 0.049 μM), 11 (IC 50 = 5.7 ± 0.113 μM), 13 (IC 50 = 6.4 ± 0.148 μM), 14 (IC 50 = 10.5 ± 0.51 μM), 9 (IC 50 = 11.49 ± 0.08 μM), 3 (IC 50 = 63.1 ± 1.48 μM), 10 (IC 50 = 120.0 ± 4.47 μM), and 6 (IC 50 = 153.2 ± 5.6 μM) showed excellent phosphodiesterase inhibitory activity, much superior to the standard EDTA (IC 50 = 274 ± 0.007 μM), and thus are potential molecules for the development of a new class of phosphodiesterase inhibitors. A structure-activity relationship is evaluated. All compounds are characterized by spectroscopic parameters. © 2011 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Khan, K. M., Shah, Z., Ahmad, V. U., Ambreen, N., Khan, M., Taha, M., … Voelter, W. (2012). 6-Nitrobenzimidazole derivatives: Potential phosphodiesterase inhibitors: Synthesis and structure-activity relationship. Bioorganic and Medicinal Chemistry, 20(4), 1521–1526. https://doi.org/10.1016/j.bmc.2011.12.041

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free